Online Only Articles

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;Department of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic;Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;Department of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Department of Molecular Pathology, Royal Bournemouth Hospital, UK
Department of Laboratory Medicine, Stem Cell Center, Hematology and Transplantation, Lund University, Sweden
Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden
Hematology Department, General Hospital of Nikea, Piraeus, Greece
First Department of Propaedeutic Medicine, School of Medicine, University of Athens, Greece
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece;Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
Laboratory of Hematology, Hospital Pitie-Salpetriere and University Pierre and Marie Curie, Paris, France
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, the Netherlands
Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
Cancer Sciences, Faculty of Medicine, University of Southampton, UK
Department of Molecular Pathology, Royal Bournemouth Hospital, UK
Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece
Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;Department of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
Vol. 101 No. 9 (2016): September, 2016 https://doi.org/10.3324/haematol.2016.142968